Table 3 Expression of Ad receptor molecules after ZOL treatments
Cells | Ab | ZOL treatment | Mean fluorescent intensity (average ± SE) | % radio (average ± SE) |
|---|---|---|---|---|
MSTO-211H | 2nd Ab alone | (−) | 12.42 ± 0.07 | |
(+) | 13.44 ± 0.07 | 108.19 ± 0.51 | ||
CAR | (−) | 95.21 ± 2.04 | ||
(+) | 95.86 ± 0.09 | 100.69 ± 0.09 | ||
Integrin αvβ3 | (−) | 13.59 ± 0.02 | ||
(+) | 14.67 ± 0.04 | 107.92 ± 0.04 | ||
Integrin αvβ5 | (−) | 15.64 ± 0.10 | ||
(+) | 18.12 ± 0.03 | 115.88 ± 0.64 | ||
NCI-H28 | 2nd Ab alone | (−) | 11.39 ± 0.03 | |
(+) | 11.55 ± 0.86 | 101.38 ± 0.79 | ||
CAR | (−) | 127.26 ± 0.31 | ||
(+) | 119.29 ± 0.69 | 93.73 ± 0.03 | ||
Integrin αvβ3 | (−) | 1006.61 ± 1.24 | ||
(+) | 718.29 ± 2.33 | 71.36 ± 0.12 | ||
Integrin αvβ5 | (−) | 44.01 ± 0.09 | ||
(+) | 22.01 ± 0.03 | 50.01 ± 0.13 |